Search results
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WHTC 1450 Holland· 7 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
1 Top Dividend Stock to Load Up On Now
The Motley Fool via AOL· 2 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 22 hours agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma ...
Roses. Butter-poached lobster. Obama cameo. Takeaways from the White House state dinner
USA TODAY via Yahoo News· 6 hours agoThere were members of Congress and administration as well as business leaders such as Albert Bourla,...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 7 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 2 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
Explainer-What are the FLiRT COVID variants and are they more contagious?
KFGO· 5 hours agoBy Michael Erman NEW YORK (Reuters) - The so-called FLiRT variants of SARS-CoV-2 coronavirus that...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 3 days agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
Pfizer Tax Practices Targeted by Congress in Wider Pharma Probe
Bloomberg Law· 3 days agoSenate Finance Chair Ron Wyden (D-Ore.) demanded information into the tax practices of Pfizer Inc., expanding his panel’s probe into the profit-shifting practices of US pharmaceutical companies.
Pfizer to Cut Costs in Multi-Year Effort — Update
Morningstar· 2 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio enhancements. The first ...